COM:ENLIVEX
Enlivex Therapeutics
- Stock
Last Close
0.84
22/11 21:00
Market Cap
29.22M
Beta: -
Volume Today
221.59K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -15.60M - | -21.70M 39.11% | -5.51M 74.60% | 588.50K 110.67% | |||||||
average payables | 1.16M - | 1.85M 58.73% | 1.06M 42.80% | 359.50K 65.96% | 96K 73.30% | 244.50K 154.69% | 389.50K 59.30% | 670.50K 72.14% | 1.41M 110.74% | 1.39M 1.80% | |
average receivables | 201.50K - | 667K 231.02% | 861.50K 29.16% | 345.50K 59.90% | 120.50K 65.12% | 1.31M 985.48% | 1.78M 36.35% | 1.68M 5.72% | 1.42M 15.37% | 323.50K 77.27% | |
book value per share | 100.08 - | 50.40 49.64% | 21.88 56.60% | 7.38 66.25% | 2.77 62.54% | 1.30 52.84% | 2.69 106.59% | 4.76 76.70% | 3.09 35.10% | 1.62 47.59% | |
capex per share | -0.21 - | -0.13 34.36% | -0.05 66.45% | -0.00 89.68% | -0.13 2,712.76% | -0.02 83.01% | -0.08 246.77% | -0.09 17.59% | -0.44 385.27% | -0.01 97.12% | |
capex to depreciation | -12.60 - | -2.82 77.59% | -0.47 83.22% | -0.03 93.40% | -3.81 12,091.74% | -0.94 75.41% | -3.56 280.29% | -2.98 16.47% | -10.45 251.22% | -0.28 97.30% | |
capex to operating cash flow | 0.01 - | 0.00 74.65% | 0.00 67.92% | 0.00 72.91% | 0.15 46,218.76% | 0.03 81.20% | 0.09 237.74% | 0.09 0.06% | 0.34 266.04% | 0.01 97.04% | |
capex to revenue | -0.45 - | ||||||||||
cash per share | 34.53 - | 20.48 40.69% | 17.28 15.63% | 8.23 52.35% | 2.79 66.17% | 1.39 50.16% | 2.71 95.30% | 4.71 73.73% | 2.62 44.47% | 1.48 43.54% | |
days of inventory on hand | |||||||||||
days payables outstanding | 361.50 - | ||||||||||
days sales outstanding | 186.59 - | ||||||||||
debt to assets | 0.01 - | 0.01 28.19% | 0.01 28.92% | 0.07 1,005.00% | 0.01 86.89% | ||||||
debt to equity | 0.01 - | 0.01 47.53% | 0.01 26.84% | 0.09 1,075.29% | 0.01 86.51% | ||||||
dividend yield | |||||||||||
earnings yield | -0.09 - | -0.28 211.26% | -0.97 247.15% | -0.78 19.29% | -0.20 75.02% | -0.14 28.38% | -0.12 10.71% | -0.09 30.78% | -0.59 576.96% | -0.58 0.94% | |
enterprise value | 67.76M - | 47.79M 29.47% | 9.67M 79.76% | 4.08M 57.82% | 11.99M 193.83% | 68.74M 473.50% | 105.55M 53.54% | 101.04M 4.27% | 29.50M 70.80% | 50.26M 70.36% | |
enterprise value over ebitda | -9.58 - | -3.09 67.72% | -0.61 80.23% | -0.69 13.26% | -1.97 183.95% | -9.27 371.66% | -14.58 57.27% | -4.25 70.84% | -1.56 63.35% | -2.09 33.89% | |
ev to operating cash flow | -15.37 - | -3.61 76.53% | -0.62 82.68% | -0.64 2.84% | -3.79 490.44% | -9.76 157.47% | -9.59 1.79% | -5.76 39.93% | -1.23 78.62% | -2.14 73.47% | |
ev to sales | 46.35 - | ||||||||||
free cash flow per share | -14.59 - | -37.38 156.16% | -38.99 4.31% | -14.84 61.94% | -1.03 93.04% | -0.84 18.97% | -0.91 9.19% | -1.07 17.52% | -1.74 62.48% | -1.28 26.64% | |
free cash flow yield | -0.06 - | -0.24 322.96% | -0.94 288.17% | -0.84 10.86% | -0.17 80.04% | -0.10 40.21% | -0.11 8.67% | -0.17 58.51% | -0.44 157.74% | -0.47 7.05% | |
graham net net | 27.76 - | 15.45 44.34% | 13.67 11.51% | 7.21 47.28% | 2.45 65.97% | 0.87 64.50% | 1.22 40.48% | 3.90 218.43% | 2.09 46.42% | 1.11 46.64% | |
graham number | 227.14 - | 221.32 2.56% | 140.82 36.37% | 48.02 65.90% | 8.67 81.94% | 5.87 32.34% | 7.99 36.14% | 7.61 4.78% | 12.66 66.42% | 7.55 40.35% | |
income quality | 0.63 - | 0.86 37.33% | 0.97 12.09% | 1.07 10.54% | 0.75 30.26% | 0.75 0.69% | 0.93 24.07% | 1.21 30.25% | 0.77 36.40% | 0.81 4.93% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.02 Infinity% | 0 100% | 0 | 0 | 0 | |
interest coverage | -4.90 - | -1.78K 36,226.50% | |||||||||
interest debt per share | 0.01 - | 0.02 8.40% | 0.03 124.12% | 0.55 1,490.90% | 0.02 96.47% | ||||||
inventory turnover | |||||||||||
invested capital | 0.01 - | 0.01 47.53% | 0.01 26.84% | 0.09 1,075.29% | 0.01 86.51% | ||||||
market cap | 78.34M - | 55.07M 29.70% | 16.54M 69.96% | 7.61M 54.02% | 21.72M 185.62% | 72.57M 234.07% | 111.02M 52.98% | 111.62M 0.55% | 72.48M 35.07% | 50.15M 30.80% | |
net current asset value | 30.61M - | 17.81M 41.81% | 8.61M 51.65% | 3.16M 63.28% | 8.95M 183.02% | 10.14M 13.34% | 33.25M 227.81% | 76.33M 129.58% | 41.53M 45.60% | 27.02M 34.94% | |
net debt to ebitda | 1.50 - | 0.47 68.49% | 0.43 7.89% | 0.60 37.79% | 1.60 166.84% | 0.52 67.69% | 0.76 46.48% | 0.45 41.05% | 2.27 409.64% | -0.00 100.19% | |
net income per share | -22.91 - | -43.19 88.51% | -40.29 6.71% | -13.88 65.54% | -1.21 91.29% | -1.17 2.93% | -1.05 10.29% | -0.54 48.68% | -2.31 326.75% | -1.56 32.12% | |
operating cash flow per share | -14.39 - | -37.24 158.88% | -38.94 4.57% | -14.83 61.91% | -0.90 93.93% | -0.81 9.63% | -0.84 2.68% | -0.98 17.52% | -1.30 32.57% | -1.27 2.74% | |
payables turnover | 1.01 - | ||||||||||
receivables turnover | 1.96 - | ||||||||||
research and ddevelopement to revenue | 2.67 - | ||||||||||
return on tangible assets | -0.21 - | -0.75 251.47% | -1.51 101.25% | -1.64 8.90% | -0.38 76.58% | -0.59 53.93% | -0.34 41.95% | -0.10 70.48% | -0.63 518.26% | -0.79 25.89% | |
revenue per share | 0.17 - | ||||||||||
roe | -0.23 - | -0.86 274.29% | -1.84 114.95% | -1.88 2.08% | -0.44 76.75% | -0.90 105.83% | -0.39 56.57% | -0.11 70.96% | -0.75 557.59% | -0.97 29.51% | |
roic | -0.23 - | -0.86 274.50% | -1.85 113.89% | -1.89 2.35% | -0.68 63.96% | -0.81 18.57% | -0.32 60.47% | -0.15 53.36% | -0.56 278.96% | -0.80 41.80% | |
sales general and administrative to revenue | 1.58 - | ||||||||||
shareholders equity per share | 100.08 - | 50.40 49.64% | 21.88 56.60% | 7.38 66.25% | 2.77 62.54% | 1.30 52.84% | 2.69 106.59% | 4.76 76.70% | 3.09 35.10% | 1.62 47.59% | |
stock based compensation to revenue | 0.29 - | ||||||||||
tangible asset value | 30.67M - | 17.93M 41.54% | 8.70M 51.49% | 3.16M 63.65% | 9.71M 206.96% | 10.87M 12.01% | 35.49M 226.41% | 85.04M 139.63% | 56.84M 33.16% | 30.08M 47.07% | |
tangible book value per share | 100.08 - | 50.40 49.64% | 21.88 56.60% | 7.38 66.25% | 2.77 62.54% | 1.26 54.55% | 2.69 114.38% | 4.76 76.70% | 3.09 35.10% | 1.62 47.59% | |
working capital | 30.61M - | 17.88M 41.58% | 8.61M 51.84% | 3.16M 63.28% | 9.15M 189.28% | 10.44M 14.15% | 33.75M 223.24% | 81.72M 142.15% | 45.72M 44.05% | 27.70M 39.41% |
All numbers in USD (except ratios and percentages)